About Prognica Labs
Prognica Labs is a Dubai-based healthtech company that develops artificial intelligence to support breast cancer screening. Its technology analyses mammograms, the X-ray images used to screen for breast cancer, to help radiologists detect signs of cancer earlier and more accurately.
Breast cancer is one of the most common cancers among women worldwide, including in the Gulf. Early detection significantly improves the chances of successful treatment, which is why screening programmes are widely recommended. However, reading mammograms is complex and time-consuming, and subtle signs of cancer can be missed.
Prognica's AI system is trained to identify patterns in mammograms that may indicate cancer, such as masses or calcifications. It highlights areas of concern for radiologists to review, acting as a second set of eyes. The goal is not to replace radiologists, but to support them, improving accuracy and helping them work more efficiently.
AI-assisted screening can be particularly valuable where there are shortages of specialised radiologists or large screening volumes. By helping prioritise cases that need urgent attention, AI tools can speed up diagnosis and reduce waiting times.
Medical AI must meet strict requirements for accuracy, safety and regulatory approval before it can be used in clinical settings. Developing such tools involves training on large sets of medical images and validating results in real clinical environments.
Prognica works with hospitals, imaging centres and healthcare providers that run breast screening services.
The UAE has promoted breast cancer awareness and screening through national campaigns, and healthcare authorities encourage regular screening for women in eligible age groups. Increasing screening participation creates more demand for efficient image analysis.
The UAE's national AI strategy identifies healthcare as a priority sector, and regulators have been open to AI-assisted medical tools that meet safety standards.
Prognica's focus on earlier breast cancer detection gives it a clear and important purpose, and Startups UAE profiles it among Dubai's medical AI startups.
Breast cancer is one of the most common cancers among women worldwide, including in the Gulf. Early detection significantly improves the chances of successful treatment, which is why screening programmes are widely recommended. However, reading mammograms is complex and time-consuming, and subtle signs of cancer can be missed.
Prognica's AI system is trained to identify patterns in mammograms that may indicate cancer, such as masses or calcifications. It highlights areas of concern for radiologists to review, acting as a second set of eyes. The goal is not to replace radiologists, but to support them, improving accuracy and helping them work more efficiently.
AI-assisted screening can be particularly valuable where there are shortages of specialised radiologists or large screening volumes. By helping prioritise cases that need urgent attention, AI tools can speed up diagnosis and reduce waiting times.
Medical AI must meet strict requirements for accuracy, safety and regulatory approval before it can be used in clinical settings. Developing such tools involves training on large sets of medical images and validating results in real clinical environments.
Prognica works with hospitals, imaging centres and healthcare providers that run breast screening services.
The UAE has promoted breast cancer awareness and screening through national campaigns, and healthcare authorities encourage regular screening for women in eligible age groups. Increasing screening participation creates more demand for efficient image analysis.
The UAE's national AI strategy identifies healthcare as a priority sector, and regulators have been open to AI-assisted medical tools that meet safety standards.
Prognica's focus on earlier breast cancer detection gives it a clear and important purpose, and Startups UAE profiles it among Dubai's medical AI startups.